Skip to main content

Sinuva FDA Approval History

Last updated by Judith Stewart, BPharm on Dec 10, 2017.

FDA Approved: Yes (First approved December 8, 2017)
Brand name: Sinuva
Generic name: mometasone furoate
Dosage form: Sinus Implant
Company: Intersect ENT, Inc.
Treatment for: Nasal Polyps

Sinuva (mometasone furoate) is a corticosteroid-eluting sinus implant indicated for the treatment of recurrent nasal polyp disease.

Important Safety Information

Development timeline for Sinuva

DateArticle
Dec 11, 2017Approval Intersect ENT Announces FDA Approval of Sinuva (mometasone furoate) Sinus Implant, a New In-Office Treatment Option for Recurrent Nasal Polyps

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.